Trial Information
Inclusion Criteria:
- Patients with CML
Type of Study:
Interventional
Study Design:
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Outcome Measure:
safety and efficacy
Outcome Time Frame:
10 years
Safety Issue:
No
Principal Investigator
Naeeem Chaudhri, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
King Faisal Specialist Hospital & Research Centre
Authority:
United States: Institutional Review Board
Study ID:
RAC #2051-056
NCT ID:
NCT00538447
Start Date:
June 2007
Completion Date:
June 2020
Related Keywords:
- Leukemia, Myeloid, Chronic
- CML
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive